Literature DB >> 30462305

Sexually Acquired Hepatitis C Infection in HIV-Uninfected Men Who Have Sex With Men Using Preexposure Prophylaxis Against HIV.

Jennifer C Price1, Jeffrey E McKinney1, Pierre-Cedric Crouch2, Stephen M Dillon3, Asa Radix4, Alicia Stivala4, Jesse R Carollo5, Daniel S Fierer5.   

Abstract

Sexually acquired hepatitis C virus (HCV) infections among human immunodeficiency virus (HIV)-uninfected men who have sex with men (MSM) have been rare. With the introduction of preexposure prophylaxis (PrEP) against HIV, we hypothesized that these infections would increase. Between 2013 and 2018, we diagnosed 15 likely sexually acquired HCV infections among 14 MSM using PrEP. Most (87%) were asymptomatic, detected by routine alanine transaminase (ALT) or HCV monitoring. Half reported increasing sex partners and drug use after starting PrEP; 5 reported injection of methamphetamine. Interventions are needed to prevent sexually acquired HCV infections by MSM using PrEP. Centers for Disease Control and Prevention guidelines for monitoring during PrEP should include regular ALT and HCV testing.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  acute hepatitis C virus; men who have sex with men; methamphetamine; preexposure prophylaxis; sexual transmission

Mesh:

Year:  2019        PMID: 30462305     DOI: 10.1093/infdis/jiy670

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation.

Authors:  Victoria E Powell; Kevin M Gibas; Joshua DuBow; Douglas S Krakower
Journal:  Curr Infect Dis Rep       Date:  2019-06-21       Impact factor: 3.725

2.  Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis.

Authors:  Natasha K Martin; Klaus Jansen; Matthias An der Heiden; Christoph Boesecke; Anders Boyd; Knud Schewe; Axel Baumgarten; Thomas Lutz; Stefan Christensen; Alexander Thielen; Stefan Mauss; Jürgen K Rockstroh; Britt Skaathun; Patrick Ingiliz
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

Review 3.  A review of network simulation models of hepatitis C virus and HIV among people who inject drugs.

Authors:  Meghan Bellerose; Lin Zhu; Liesl M Hagan; William W Thompson; Liisa M Randall; Yelena Malyuta; Joshua A Salomon; Benjamin P Linas
Journal:  Int J Drug Policy       Date:  2019-11-15

4.  Immunological Changes in Monocyte Subsets and Their Association With Foxp3+ Regulatory T Cells in HIV-1-Infected Individuals With Syphilis: A Brief Research Report.

Authors:  Na Guo; Lifeng Liu; Xiaodong Yang; Ting Song; Guanxin Li; Li Li; Taiyi Jiang; Yanqing Gao; Tong Zhang; Bin Su; Hao Wu
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

Review 5.  Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men.

Authors:  Bernadien M Nijmeijer; Jelle Koopsen; Janke Schinkel; Maria Prins; Teunis Bh Geijtenbeek
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

6.  The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.

Authors:  David Chromy; David J M Bauer; Benedikt Simbrunner; Matthias Jachs; Lukas Hartl; Philipp Schwabl; Caroline Schwarz; Armin Rieger; Katharina Grabmeier-Pfistershammer; Michael Trauner; Peter Ferenci; Mattias Mandorfer; Michael Gschwantler; Thomas Reiberger
Journal:  J Viral Hepat       Date:  2022-03-15       Impact factor: 3.517

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.